Patent · US Active

E. coli specific antibodies

US12103962B2 · kind B2 · utility

0Cited by
6References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 19, 2014
Grant dateOct 1, 2024
Priority date
Expiry dateDec 19, 2034

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention refers to an isolated antibody that specifically binds to O25b antigen of E. coli strains comprising at least an antibody heavy chain variable region (VH), which comprises any of the CDR1 to CDR3 sequences as listed in FIG. 1, and optionally further comprising an antibody light chain variable region (VL), which comprises any of the CDR4 to CDR6 sequences as listed in FIG. 1, or functionally active CDR variants of any of the forgoing CDR 1-6 sequences.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.